CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.370
+0.080 (2.43%)
Aug 25, 2026, 4:00 PM EDT - Market closed
CytomX Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $11 | Buy | Maintains | $11 | +226.41% | Aug 17, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +256.08% | Aug 7, 2026 |
| Barclays | Barclays | Buy Maintains $16 | Buy | Maintains | $16 | +374.78% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +315.43% | Aug 7, 2026 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +226.41% | Jun 4, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $6 | Buy | Initiates | $6 | +78.04% | May 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $17 → $11 | Buy | Maintains | $17 → $11 | +226.41% | May 11, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +256.08% | Mar 20, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.